Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
HRTXHeron Therapeutics(HRTX) ZACKS·2024-08-07 08:31

Heron Therapeutics (HRTX) reported 36.02millioninrevenueforthequarterendedJune2024,representingayear−over−yearincreaseof13.436.02 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 13.4%. EPS of -0.06 for the same period compares to -0.35ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof0.35 a year ago.The reported revenue compares to the Zacks Consensus Estimate of 35.35 million, representing a surprise of +1.91%. The company delivered an EPS surprise of -50.00%, with the consensus EPS estimate being -$0.04.While investors closely watch year-over-year changes in headline numbers -- revenue and earnin ...